Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo has shown efficacy in immunocompromised adults, the pharma announced Monday. In substudy B of Pfizer’s ongoing Phase 3 MONeT trial, Abrysvo ...

A proposal to redevelop the former 148-acre Pfizer office campus on Route 206 into a senior housing community received ...

NEW YORK & BOTHELL, Wash.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will ...

Jeff Kindler, a biopharma executive who helped steer Pfizer’s $68 billion merger with Wyeth, is looking for a healthy return on his Upper West Side home. Kindler and his wife, Sharon Sullivan, who ...

Pfizer expects to launch Zavicefta in additional markets outside the U.S. throughout 2017 and 2018. Zavicefta was developed in response to the urgent medical need for new antibiotics for ...

After losing round one of its respiratory syncytial virus (RSV) vaccine bout with GSK, Pfizer is rallying. And what better way to do it than to win a major contract in your rival’s home country? The U ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), The ...

On this episode of Stock Movers: - Home Depot (HD) shares rise after the company maintained its guidance for the fiscal year despite a 0.3% drop in comparable sales, as US sales ticked up due to ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc., The Home ...